— Know what they know.
Not Investment Advice
Also trades as: IPD.AX (ASX) · $vol 0M

IPDQF OTC

ImpediMed Limited
1W: -18.2% 1M: -15.9% 3M: -18.2% YTD: -81.8% 1Y: -83.3% 3Y: -95.9% 5Y: -94.9%
$0.00
-0.00 (-18.18%)
 
Weekly Expected Move ±22.8%
$0 $0 $0 $0 $0
OTC · Healthcare · Medical - Devices · Tech Score Sell · Power 50 · $16.5M mcap · 3.43B float · 0.0023% daily turnover · Short 69% of daily vol
Smart Money Score
No convergence signal
Key Statistics
Market Cap$16.5M
52W Range0.002-0.0409
Volume430,000
Avg Volume78,258
Beta1.09
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOErik Anderson
Employees66
SectorHealthcare
IndustryMedical - Devices
IPO Date2012-09-25
5900 Pasteur Court
Carlsbad, CA 92008
US
61 7 3860 3700
About ImpediMed Limited

ImpediMed Limited is a medical technology firm that specializes in software solutions. The company is involved in the creation, production, and global distribution of sophisticated bioimpedance spectroscopy (BIS) equipment and its accompanying software applications, serving markets in Australia, North America, and beyond. Its principal offerings include: SOZO: A non-intrusive BIS device engineered for the evaluation of lymphedema and for tracking fluid levels in individuals afflicted with heart failure. SFB7: A single-channel, tetrapolar BIS instrument utilized to assess the body composition of healthy individuals. ImpediVET: Another single-channel, tetrapolar BIS device, tailored specifically for veterinary applications to measure fluid status and tissue characteristics in animals. ImpediMed primarily markets its advanced medical devices to healthcare institutions such as hospitals and clinics. The company was founded in 1999 and its headquarters are located in Pinkenba, Australia.

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms